125 related articles for article (PubMed ID: 21738055)
1. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.
Ude M; Schuessel K; Quinzler R; Leuner K; Müller WE; Schulz M
J Hypertens; 2011 Sep; 29(9):1837-45. PubMed ID: 21738055
[TBL] [Abstract][Full Text] [Related]
2. Generic substitution of antihypertensive drugs: does it affect adherence?
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
[TBL] [Abstract][Full Text] [Related]
3. Dispensing pattern of generic and brand-name drugs in children.
Chen AY; Wu S
Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
[TBL] [Abstract][Full Text] [Related]
4. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
5. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
Rathe JØ
Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
[TBL] [Abstract][Full Text] [Related]
6. Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.
Halkin H; Dushenat M; Silverman B; Shalev V; Loebstein R; Lomnicky Y; Friedman N
Ann Pharmacother; 2007 Jan; 41(1):29-34. PubMed ID: 17190847
[TBL] [Abstract][Full Text] [Related]
7. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use.
Zedler BK; Joyce A; Murrelle L; Kakad P; Harpe SE
Clin Ther; 2011 May; 33(5):581-97. PubMed ID: 21665043
[TBL] [Abstract][Full Text] [Related]
9. Effect of generic-only drug benefits on seniors' medication use and financial burden.
Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
[TBL] [Abstract][Full Text] [Related]
10. Medication persistence and the use of generic and brand-name blood pressure-lowering agents.
Corrao G; Soranna D; La Vecchia C; Catapano A; Agabiti-Rosei E; Gensini G; Merlino L; Mancia G
J Hypertens; 2014 May; 32(5):1146-53; discussion 1153. PubMed ID: 24569417
[TBL] [Abstract][Full Text] [Related]
11. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
12. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
Layton S; Barbeau M
Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
[TBL] [Abstract][Full Text] [Related]
13. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
Kalisch LM; Roughead EE; Gilbert AL
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):620-5. PubMed ID: 18324613
[TBL] [Abstract][Full Text] [Related]
14. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
15. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims.
McHorney CA; Victor Spain C; Alexander CM; Simmons J
Clin Ther; 2009 Nov; 31(11):2584-607. PubMed ID: 20110004
[TBL] [Abstract][Full Text] [Related]
16. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY
Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
18. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
Rodin HA; Heaton AH; Wilson AR; Garrett NA; Plocher DW
Am J Manag Care; 2009 Dec; 15(12):881-8. PubMed ID: 20001169
[TBL] [Abstract][Full Text] [Related]
19. Adherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claims.
Mano Y; Fukushima S; Kuroda H; Ohshima H; Kato Y; Ohuchi K; Maezawa K; Momose Y; Ikeda S; Asahi M
J Pharm Health Care Sci; 2015; 1():12. PubMed ID: 26819723
[TBL] [Abstract][Full Text] [Related]
20. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
